About the Company
Meridian Bioscience Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.The company is dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, Meridian provides critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, Meridian provides diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. The company builds relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $VIVO News
Meridian Bioscience, Inc.
Get to Know Us Find out about Meridian Meridian Bioscience is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, ...
Meridian Bioscience Stock Hits New 52-Week High (VIVO)
Shares are up 11.1% year to date as of the close of trading on Thursday. Meridian Bioscience, Inc. operates as an integrated life science company. The company primarily engages in the development ...
Meridian investing $100+ million in North St. Louis County expansion
Meridian Medical Technologies, a Kindeva Drug Delivery Company, announced it will expand manufacturing capabilities in Bridgeton, Missouri, investing more than $100 million over the next four ...
Neurocrine Biosciences upgraded at Wells Fargo on pipeline
Wells Fargo upgraded Neurocrine Biosciences (NASDAQ:NBIX) from equal weight to overweight on the strength of its pipeline. The firm also upped its price target to $170 from $140 (~21% upside based on ...
HRMY Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the ...
CLRB Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug ...
Pulse Biosciences, Inc. (PLSE)
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript March 28, 2024 Pulse Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...
Cogent Biosciences, Inc.
Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase ...
Anixa Biosciences, Inc.
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following ...
Meridian Bioscience Stock Hits New 52-Week Low (VIVO)
Shares are down 32% year to date as of the close of trading on Friday. Meridian Bioscience, Inc. operates as an integrated life science company. The company primarily engages in the development ...
Meridian Bioscience
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, rare reagents, specialty biologicals and ...
Meridian Bioscience
Meridian Bioscience provides diagnostic test kits, purified reagents, and related products essential for the early identification and treatment of infectious diseases and other medical conditions.
Loading the latest forecasts...